318 filings
Page 2 of 16
POS AM
nc7 5ifrs
20 Jul 18
Prospectus update (post-effective amendment)
4:09pm
POS AM
4tpcbxsvwoat8n4nzj6
20 Jul 18
Prospectus update (post-effective amendment)
4:06pm
POS AM
httks4t2ikh
20 Jul 18
Prospectus update (post-effective amendment)
4:05pm
POS AM
vykx1cbe2
20 Jul 18
Prospectus update (post-effective amendment)
4:03pm
25
ktk0mbsf
17 Jul 18
Voluntary exchange delisting
2:37pm
8-K
2ye9jm
9 Jul 18
Anthera Pharmaceuticals Announces SEC Deregistration
4:39pm
8-K
8s4j67xzv3
27 Jun 18
Anthera Pharmaceuticals Announces Withdrawal of its Nasdaq Hearing Request
4:12pm
8-K
t4amx2r3e1lu3p
18 Jun 18
Departure of Directors or Certain Officers
4:30pm
8-K
pzwm0
30 May 18
Other Events
5:25pm
8-K
ro0xm 56dslii42ak
23 May 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:25pm
8-K
v4r4n2te3atz zsfb
16 Apr 18
Cost Associated with Exit or Disposal Activities
12:00am
EFFECT
ja5pxg j6cgm
27 Mar 18
Notice of effectiveness
12:00am
8-K
ry4k e9hafikc
12 Mar 18
Anthera Pharmaceuticals Reports Top Line Data from
12:00am
8-K
7ofogp5 55xpwu
5 Mar 18
Anthera Pharmaceuticals Provides Business Update and Reports
12:00am
8-K
zqu5mbu5c nskyilz
25 Jan 18
Anthera Receives Positive Nasdaq Listing Determination
12:00am
D/A
54h sawe38h
11 Jan 18
$15M in equity / options, sold $15M, 21 investors
12:00am
8-K
5aingvf8aarjitwrg7
9 Jan 18
Anthera Pharmaceuticals Announces Second Closing of $15 Million Private Placement Offering
12:00am